Comparative Plasma and Cerebrospinal Fluid Pharmacokinetics of Paracetamol After Intravenous and Oral Administration

被引:29
|
作者
Langford, Roger A. [1 ,8 ]
Hogg, Malcolm [1 ,2 ]
Bjorksten, Andrew R. [1 ,2 ,3 ]
Williams, Daryl L. [1 ,2 ,4 ]
Leslie, Kate [1 ,2 ,5 ,6 ]
Jamsen, Kris [7 ]
Kirkpatrick, Carl [7 ]
机构
[1] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Melbourne, Vic, Australia
[2] Univ Melbourne, Anaesthesia Perioperat & Pain Med Unit, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia
[6] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
[7] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Melbourne, Vic, Australia
[8] Royal Cornwall Hosp, Dept Anaesthesia, Truro TR1 3LJ, Cornwall, England
来源
ANESTHESIA AND ANALGESIA | 2016年 / 123卷 / 03期
关键词
ACETAMINOPHEN; CHILDREN; MECHANISMS; ANALGESIA; PAIN;
D O I
10.1213/ANE.0000000000001463
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: We compared plasma and cerebrospinal fluid (CSF) pharmacokinetics of paracetamol after intravenous (IV) and oral administration to determine dosing regimens that optimize CSF concentrations. METHODS: Twenty-one adult patients were assigned randomly to 1 g IV, 1 g oral or 1.5 g oral par6cetamol. An IV cannula and lumbar intrathecal catheter were used to sample venous blood and CSF, respectively, over 6 hours. The plasma and CSF maximum concentrations (C-max), times to maximum concentrations (Tmax), and area under the plasma and CSF concentration-time curves (AUCs) were calculated using noncompartmental techniques. Significance was defined by P <.0167 (Bonferroni correction for 3 comparisons for each parameter). Probability (X < Y) (p") with Bonferroni corrected 95% confidence intervals (Cis) were calculated (Cls including 0.5 meet the null hypothesis). 'Results are presented as median (range) or p '' (CI). P values are listed as 1 g IV vs 1 g orally, 1 g IV vs 1.5 g orally and 1 g orally vs 1.5 g orally, respectively. RESULTS: Wide variation in measured paracetamol concentrations was observed, especially in the oral groups. The median plasma C-max in the 1 g IV group was significantly greater than the oral groups. In contrast, the median CSF C-max was not different between groups. The median plasma T-max in the 1 g IV group was 105 and 75 minutes earlier than in the 1 and 1.5 g oral groups. The median CSF T-max was not significantly different between groups. The median plasma AUC (total) was not significantly different between groups; however, in the first hour, the median plasma AUC was significantly greater in the IV group than in the oral groups. In the second hour, there was no difference between groups. The median CSF AUC (total) did not significantly differ between groups; however, in the first hour, the median CSF AUC was significantly greater in the IV compared with the orally groups. In the second hour, there was no difference between groups. Our analysis indicated that the median C-max, T-max, and AUC values lacked precision because of small sample sizes. CONCLUSIONS: Peak plasma.concentrations were greater and reached earlier after IV than oral dosing. Evidence for differences in CSF C-max and T-max was lacking because of the small size of this study.
引用
收藏
页码:610 / 615
页数:6
相关论文
共 50 条
  • [1] Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates
    Kerr, JZ
    Berg, SL
    Dauser, R
    Nuchtern, J
    Egorin, MJ
    McGuffey, A
    Aleksic, A
    Blaney, S
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (05) : 411 - 414
  • [2] Population pharmacokinetics of oxycodone in plasma and cerebrospinal fluid after epidural and intravenous administration
    Lamminsalo, M.
    Piirainen, P.
    Kokki, H.
    Knibbe, C. A. J.
    Ranta, V-P
    Valitaloa, P.
    Kokki, Merja
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (06) : 649 - 656
  • [3] Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates
    Jody Z. Kerr
    Stacey L. Berg
    Robert Dauser
    Jed Nuchtern
    Merrill J. Egorin
    Leticia McGuffey
    Alexander Aleksic
    Susan Blaney
    [J]. Cancer Chemotherapy and Pharmacology, 2001, 47 : 411 - 414
  • [4] PHARMACOKINETICS OF PARACETAMOL (ACETAMINOPHEN) AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    RAWLINS, MD
    HENDERSON, DB
    HIJAB, AR
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (04) : 283 - 286
  • [5] Cerebrospinal Fluid and Plasma Pharmacokinetics of Phenobarbital after Intravenous Administration to Patients with Status Epilepticus
    B. Brzaković
    M. Pokrajac
    E. Dzoljić
    Z. Lević
    V. M. Varagić
    [J]. Clinical Drug Investigation, 1997, 14 : 307 - 313
  • [6] Cerebrospinal fluid and plasma pharmacokinetics of phenobarbital after intravenous administration to patients with status epilepticus
    Brzakovic, B
    Pokrajac, M
    Dzoljic, E
    Levic, Z
    Varagic, VM
    [J]. CLINICAL DRUG INVESTIGATION, 1997, 14 (04) : 307 - 313
  • [7] Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children
    Anderson, BJ
    Holford, NHG
    Woollard, GA
    Chan, PLS
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (03) : 237 - 243
  • [8] Cerebrospinal fluid pharmacokinetics of paracetamol after intravenous propacetamol in a former preterm infant
    Allegaert, K
    Verbesselt, R
    Devlieger, H
    de Hoon, J
    Tibboel, D
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (02) : 224 - 225
  • [9] The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates
    AeRang Kim
    Cindy McCully
    Rafael Cruz
    Diane E. Cole
    Elizabeth Fox
    Frank M. Balis
    Brigitte C. Widemann
    [J]. Investigational New Drugs, 2012, 30 : 524 - 528
  • [10] Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates
    Jamie Renbarger
    Alexander Aleksic
    Leticia McGuffey
    Robert Dauser
    Stacey Berg
    Susan Blaney
    [J]. Cancer Chemotherapy and Pharmacology, 2004, 53 : 39 - 42